Circassia Group Plc

(CSSPF)

By |

Profile

Circassia Group PLC is a biotechnology company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of revenue from the US and also has a presence in EU, Asia Pacific and Rest of world.

Contact Information

Website: www.circassia.com
Email: ir@circassia.com
Main Phone: +44 1865405560
Address: Robert Robinson Avenue
Address 2: Northbrook House
State: Oxfordshire
City / Town: Oxford
Country: GB
Postal Code: OX4 4GA

Issuer Information

Exchange: GREY
CEO: Steven Charles Andrew Harris
Employees: 340

Equities News

Profile

Circassia Group PLC is a biotechnology company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of revenue from the US and also has a presence in EU, Asia Pacific and Rest of world.

Contact Information

Website: www.circassia.com
Email: ir@circassia.com
Main Phone: +44 1865405560
Address: Robert Robinson Avenue
Address 2: Northbrook House
State: Oxfordshire
City / Town: Oxford
Country: GB
Postal Code: OX4 4GA

Issuer Information

Exchange: GREY
CEO: Steven Charles Andrew Harris
Employees: 340

Equities News

$ 0.35 $ 0. (0.00%)
Last Price 0.35 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.35
Last Trade Volume 95 52 Wk Hi 0.75 52 Wk Low 0.22
Market Cap 139.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 397,645,512.00 EPS (TTM) -0.38 PE Ratio -2.60 Exchange Greys